Management ChangeJul 27, 2026, 07:36 AM
Precision BioSciences promotes Alex Kelly to COO, appoints Naresh Tanna CFO
AI Summary
Precision BioSciences, Inc. announced significant changes to its senior leadership team, effective August 1, 2026. Alex Kelly was promoted from Chief Financial Officer to the newly created role of Chief Operating Officer. Naresh Tanna, previously VP of Investor Relations and Chief of Staff to the CEO, was appointed as the new Chief Financial Officer. Additionally, Mei Burris was designated as Principal Accounting Officer and Chief Accounting Officer, and other executive roles were clarified to support the advancement of the company's clinical programs.
Key Highlights
- Alex Kelly promoted from Chief Financial Officer to Chief Operating Officer, effective August 1, 2026.
- Naresh Tanna appointed as new Chief Financial Officer, effective August 1, 2026.
- Alex Kelly's annual base salary increased to $510,000 with a 45% target annual bonus.
- Naresh Tanna's annual base salary set at $400,000 with a 40% target annual bonus.
- Mei Burris designated as Principal Accounting Officer and Chief Accounting Officer.
- Leadership changes aim to support advancement of PBGENE-HBV and PBGENE-DMD programs.
Price Impact
More from DTIL